Health Score

0 Good

Metadata coverage

Abstract

ORCID

References

License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder

Award / grant

Affiliation & institutional identifiers

Affiliation

ROR ID

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

Attach ORCID iDs across 1009 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact1009 DOIs

Deposit reference lists for 718 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Medium impact718 DOIs

Add abstracts to 272 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Low impact272 DOIs

DOIs for this ISSN

Showing the top 5 of 1940 DOIs, ordered by correction priority.

#	Title	Missing	Priority	Citations
1	Antimicrobial stewardship programmes in health-care faciliti… (10.1093/jacamr/dlz072)	Abstract References ORCID	145.09	85
2	Infection prevention and control (IPC) for novel coronavirus… (10.1093/jacamr/dlaa027)	Abstract References ORCID	92.28	16
3	Redefining the antibiotic stewardship team: recommendations… (10.1093/jacamr/dlz037)	Abstract References ORCID	92.28	16
4	Antibiotic resistance in conflict settings: lessons learned… (10.1093/jacamr/dlz002)	Abstract ORCID	66.11	20
5	Knowledge, attitude and practice of healthcare workers towar… (10.1093/jacamr/dlad068)	References ORCID	62.76	17
6	MSD manual: professional version (10.1093/jacamr/dlaa042)	Abstract References ORCID	58.36	5
7	<i>Educational Resource Review:</i> Antimicrobial stewardshi… (10.1093/jacamr/dlab121)	Abstract References ORCID	58.36	5
8	Presence of the narrow-spectrum OXA-1 β-lactamase enzyme is… (10.1093/jacamr/dlac027)	Abstract ORCID	57.31	13
9	Treatment of methicillin-resistant <i>Staphylococcus aureus<… (10.1093/jacamr/dlaa114)	ORCID	56.01	173
10	Clinical challenges treating<i>Stenotrophomonas maltophilia<… (10.1093/jacamr/dlac040)	License	54.03	144
11	Communicating antimicrobial resistance: the need to go beyon… (10.1093/jacamr/dlab096)	Abstract ORCID	53.96	11
12	Antimicrobial stewardship: systems and processes for effecti… (10.1093/jacamr/dlz025)	Abstract References ORCID	52.42	4
13	Treatment of <i>Candida glabrata</i> native valve endocardit… (10.1093/jacamr/dlae042)	Abstract License	52.07	10
14	PRO: Environmental microbiological surveillance does support… (10.1093/jacamr/dlae113)	Abstract ORCID	52.07	10
15	Updated good practice recommendations for outpatient parente… (10.1093/jacamr/dlz026)	ORCID	51.42	113
16	The antibiogram: key considerations for its development and… (10.1093/jacamr/dlab060)	ORCID	50.32	102
17	Antimicrobial use in agriculture: critical review of the fac… (10.1093/jacamr/dlab178)	ORCID	47.98	82
18	PRO: The COVID-19 pandemic will result in increased antimicr… (10.1093/jacamr/dlaa049)	ORCID	47.58	79
19	Safety and efficacy of de-labelling penicillin allergy in ad… (10.1093/jacamr/dlaa123)	ORCID	47.30	77
20	<i>In vitro</i>activity of the siderophore cephalosporin, ce… (10.1093/jacamr/dlaa060)	ORCID	47.16	76
21	Acquired bedaquiline resistance during the treatment of drug… (10.1093/jacamr/dlac029)	ORCID	47.02	75
22	Antimicrobial stewardship in Australian health care (10.1093/jacamr/dlz010)	Abstract References ORCID	45.15	3
23	<i>Escherichia coli</i> strains possessing a four amino acid… (10.1093/jacamr/dlaa081)	ORCID	44.81	61
24	Antibiotic resistance: calling time on the ‘silent pandemic’ (10.1093/jacamr/dlac016)	ORCID	44.45	59
25	Impact of the COVID-19 pandemic on community antibiotic pres… (10.1093/jacamr/dlaa105)	ORCID	42.90	51
26	The emergence of azithromycin-resistant… (10.1093/jacamr/dlaa109)	ORCID	42.03	47
27	Emergence of resistant<i>Candida glabrata</i>in Germany (10.1093/jacamr/dlab122)	ORCID	40.58	41
28	P23 Assessment of knowledge, attitude and practice towards a… (10.1093/jacamr/dlac004.022)	References ORCID	38.91	5
29	Antibiotic stewardship in the era of precision medicine (10.1093/jacamr/dlac066)	ORCID	38.91	35
30	Evaluation of Vitek®2 performance for colistin susceptibilit… (10.1093/jacamr/dlaa101)	ORCID	38.29	33
31	Antibiotic resistance during and beyond COVID-19 (10.1093/jacamr/dlab052)	ORCID	37.96	32
32	Carbapenem-resistant Enterobacterales and <i>Pseudomonas aer… (10.1093/jacamr/dlac060)	ORCID	37.96	32
33	Treating infections caused by carbapenemase-producing Entero… (10.1093/jacamr/dlaa075)	ORCID	36.93	29
34	Cognitive bias: how understanding its impact on antibiotic p… (10.1093/jacamr/dlaa107)	ORCID	36.18	27
35	Antimicrobial resistance (AMR) educational video (10.1093/jacamr/dlaa015)	Abstract References ORCID	35.78	2
36	Superheroes Against Superbugs (SaS) (10.1093/jacamr/dlaa030)	Abstract References ORCID	35.78	2
37	Emerging respiratory viruses, including COVID-19: methods fo… (10.1093/jacamr/dlaa055)	Abstract References ORCID	35.78	2
38	<i>Educational Resource Review:</i> #ASPChat (10.1093/jacamr/dlab093)	Abstract References ORCID	35.78	2
39	Erratum to: <i>Education:</i> The role of the first sideroph… (10.1093/jacamr/dlab109)	Abstract References ORCID	35.78	2
40	Antimicrobial activity of ceftazidime/avibactam, ceftolozane… (10.1093/jacamr/dlab126)	ORCID	35.78	26
41	<i>Educational Resource Review:</i> Handbook of antimicrobia… (10.1093/jacamr/dlab132)	Abstract References ORCID	35.78	2
42	Systematic review of time lag between antibiotic use and ris… (10.1093/jacamr/dlad001)	ORCID	35.78	26
43	Oral clindamycin for peritonitis due to <i>Brevibacterium ca… (10.1093/jacamr/dlae128)	Abstract ORCID License	35.78	2
44	Antimicrobial Stewardship—a practical guide to implementatio… (10.1093/jacamr/dlz005)	Abstract References ORCID	35.78	2
45	ICMR’s Antimicrobial Resistance Surveillance system (<i>i</i… (10.1093/jacamr/dlab023)	ORCID	34.95	24
46	P44 Nosocomial neurosurgical meningitis due to XDR <i>Pseudo… (10.1093/jacamr/dlac004.043)	References ORCID	34.95	4
47	P22 Patient-level meta-analysis of efficacy and safety from… (10.1093/jacamr/dlac133.026)	References ORCID	34.95	4
48	Combatting antimicrobial resistance in Nepal: the need for p… (10.1093/jacamr/dlz066)	Abstract	34.95	24
49	PRO: Testing for ESBL production is necessary for ceftriaxon… (10.1093/jacamr/dlab019)	ORCID	34.51	23
50	Use of dalbavancin in infective endocarditis: a case series (10.1093/jacamr/dlab099)	ORCID	34.51	23